Your browser doesn't support javascript.
loading
The prognostic significance of immune checkpoint receptor expression in patients with lymphoma: Association with disease status and clinical outcomes.
Shokrgozar, Negin; Dehghani, Mehdi; Golmoghaddam, Hossein; Moghadam, Mohamad; Rezaei, Narges; Moayed, Vida; Arandi, Nargess.
Afiliação
  • Shokrgozar N; Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Dehghani M; Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Golmoghaddam H; Department of Hematology and Medical Oncology, Shiraz University of Medical Sciences, Namazi Hospital, Shiraz, Iran.
  • Moghadam M; Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Rezaei N; Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Moayed V; Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Arandi N; Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Asia Pac J Clin Oncol ; 18(5): e388-e397, 2022 Oct.
Article em En | MEDLINE | ID: mdl-35098660

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Linfoma Difuso de Grandes Células B Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Asia Pac J Clin Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Irã

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Linfoma Difuso de Grandes Células B Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Asia Pac J Clin Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Irã